Unique ID issued by UMIN | UMIN000021947 |
---|---|
Receipt number | R000025312 |
Scientific Title | A randomized control trial of heparin bridging versus direct oral anticoagulant (DOAC) replacement in patients who undergo endoscopic resection for colon polyps. (NHOG-DOAC-EMR) |
Date of disclosure of the study information | 2016/04/18 |
Last modified on | 2020/12/01 22:57:19 |
A randomized control trial of heparin bridging versus direct oral anticoagulant (DOAC) replacement in patients who undergo endoscopic resection for colon polyps. (NHOG-DOAC-EMR)
A randomized control trial of heparin bridging versus direct oral anticoagulant (DOAC) replacement in patients who undergo endoscopic resection for colon polyps. (NHOG-DOAC-EMR)
A randomized control trial of heparin bridging versus direct oral anticoagulant (DOAC) replacement in patients who undergo endoscopic resection for colon polyps. (NHOG-DOAC-EMR)
A randomized control trial of heparin bridging versus direct oral anticoagulant (DOAC) replacement in patients who undergo endoscopic resection for colon polyps. (NHOG-DOAC-EMR)
Japan |
Colon polyp
Gastroenterology |
Others
NO
To verify the superiority of direct oral anticoagulant replacement to heparin bridging in post polypectomy bleeding rate for patients who undergo endoscopic resection for colon polyps.
Safety,Efficacy
Post polypectomy bleeding rate
Hospitalization, endoscopic treatment results, the rate of arterial thromboembolism, severe adverse events, endoscopic execution rate
Interventional
Parallel
Randomized
Individual
Open -no one is blinded
Active
YES
YES
Institution is considered as adjustment factor in dynamic allocation.
NO
Central registration
2
Treatment
Medicine | Maneuver |
Heparin bridging before endoscopic mucosal resection
direct oral anticoagulant replacement before endoscopic mucosal resection
20 | years-old | <= |
Not applicable |
Male and Female
1)Patients who undergo endoscopic mucosal resection for colon polyps
2)Patients with non valvular atrial fibrillation, and use warfarin for prevention of thrombosis
3)PT-INR is less than 3.0
4)ages over 20 years
5)written informed consent
1)Plt is less than 50000/mm3
2)Patients who undergo hemodialysis
3)Woman who has a possibility of pregnancy or is during pregnancy
4)Impossible to suspend to one-antiplatelet medication.
5)The attending physician has determined that it is difficult to entry
160
1st name | Takuya |
Middle name | |
Last name | Yamada |
National Hospital Organization Osaka National Hospital
Gastroenterology and Hepatology
540-0006
2-1-14, Hoenzaka, Chuo-ku, Osaka
06-6942-1331
yamada@onh.go.jp
1st name | Takuya |
Middle name | |
Last name | Yamada |
National Hospital Organization Osaka National Hospital
Gastroenterology and Hepatology
540-0006
2-1-14, Hoenzaka, Chuo-ku, Osaka
06-6942-1331
yamada@onh.go.jp
National Hospital Organization
National Hospital Organization
Other
Japan
National Hospital Organization Headquarters Clinical Research Central Ethics Review Committee
2-5-21 Higashigaoka, Meguro-ku, Tokyo
03-5712-5075
700-kenkyu@mail.hosp.go.jp
NO
国立病院機構大阪医療センター(大阪府)、国立病院機構九州医療センター(福岡県)、国立病院機構呉医療センター・中国がんセンター(広島県)、国立病院機構東京医療センター(東京都)、国立病院機構三重中央医療センター(三重県)、国立病院機構災害医療センター(東京都)、国立病院機構函館病院(北海道)、国立病院機構北海道がんセンター(北海道)、国立病院機構金沢医療センター(石川県)、国立病院機構敦賀医療センター(福井県)、国立病院機構東広島医療センター(広島県)
2016 | Year | 04 | Month | 18 | Day |
Unpublished
Completed
2016 | Year | 03 | Month | 04 | Day |
2016 | Year | 04 | Month | 19 | Day |
2016 | Year | 05 | Month | 16 | Day |
2018 | Year | 05 | Month | 30 | Day |
2016 | Year | 04 | Month | 17 | Day |
2020 | Year | 12 | Month | 01 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000025312
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |